Last reviewed · How we verify
Atorvastatin and rosuvastatin oral solution
Atorvastatin and rosuvastatin oral solution is a Small molecule drug developed by Merck Sharp & Dohme LLC. It is currently in Phase 1 development.
At a glance
| Generic name | Atorvastatin and rosuvastatin oral solution |
|---|---|
| Sponsor | Merck Sharp & Dohme LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport (PHASE1)
- Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates (PHASE1)
- An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia (PHASE3)
- Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386) (PHASE1)
- Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia (PHASE4)
- Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Atorvastatin and rosuvastatin oral solution CI brief — competitive landscape report
- Atorvastatin and rosuvastatin oral solution updates RSS · CI watch RSS
- Merck Sharp & Dohme LLC portfolio CI
Frequently asked questions about Atorvastatin and rosuvastatin oral solution
What is Atorvastatin and rosuvastatin oral solution?
Atorvastatin and rosuvastatin oral solution is a Small molecule drug developed by Merck Sharp & Dohme LLC.
Who makes Atorvastatin and rosuvastatin oral solution?
Atorvastatin and rosuvastatin oral solution is developed by Merck Sharp & Dohme LLC (see full Merck Sharp & Dohme LLC pipeline at /company/merck).
What development phase is Atorvastatin and rosuvastatin oral solution in?
Atorvastatin and rosuvastatin oral solution is in Phase 1.